ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 79 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,521,501 | +41.2% | 286,535 | +153.3% | 0.00% | – |
| Q2 2023 | $1,077,920 | -67.1% | 113,108 | -62.0% | 0.00% | -100.0% |
| Q1 2023 | $3,278,231 | +604.7% | 298,021 | +848.1% | 0.00% | – |
| Q4 2022 | $465,208 | -69.8% | 31,433 | -61.0% | 0.00% | – |
| Q3 2022 | $1,539,000 | -65.7% | 80,515 | -61.7% | 0.00% | -100.0% |
| Q2 2022 | $4,483,000 | +9.6% | 210,411 | -0.9% | 0.00% | 0.0% |
| Q1 2022 | $4,091,000 | -29.5% | 212,400 | -24.1% | 0.00% | 0.0% |
| Q4 2021 | $5,806,000 | -14.9% | 279,915 | -2.0% | 0.00% | 0.0% |
| Q3 2021 | $6,826,000 | -46.4% | 285,732 | -38.7% | 0.00% | -66.7% |
| Q2 2021 | $12,725,000 | -2.8% | 466,312 | +3.1% | 0.00% | 0.0% |
| Q1 2021 | $13,089,000 | +248.0% | 452,456 | +238.4% | 0.00% | +200.0% |
| Q4 2020 | $3,761,000 | +735.8% | 133,703 | +771.0% | 0.00% | – |
| Q3 2020 | $450,000 | -55.0% | 15,350 | -53.6% | 0.00% | – |
| Q2 2020 | $1,000,000 | -39.6% | 33,089 | -40.4% | 0.00% | -100.0% |
| Q1 2020 | $1,656,000 | – | 55,565 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 8,684,232 | $46,113,272 | 3.06% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,105,309 | $5,869,191 | 2.34% |
| Bain Capital Life Sciences Investors, LLC | 3,000,000 | $15,930,000 | 1.78% |
| Sio Capital Management, LLC | 635,969 | $3,376,995 | 1.04% |
| Rubric Capital Management LP | 5,034,530 | $26,733,354 | 1.00% |
| Tejara Capital Ltd | 309,179 | $1,641,740 | 0.93% |
| AlphaCentric Advisors LLC | 165,000 | $876,150 | 0.50% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,135,227 | $6,028,055 | 0.33% |
| Orbimed Advisors | 1,914,479 | $10,165,883 | 0.22% |
| Two Seas Capital LP | 164,807 | $875,125 | 0.18% |